Back to entry
Report this entry
Let us know what's wrong. We'll take a look and act if needed.
Psychedelic Bulletin 212: Delix reports early efficacy signal, NRx urges FDA ban on ketamine competitors, Cybin raises $175M
psychedelicalpha.com